menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

PCSK9i Reduces Plaque Burden in Coronary Arteries 

ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Comments
  • Overview

    Dr. Lorenz Raber recaps the PACMAN-AMI study and how the PCSK9 inhibitor alirocumab can aid in coronary plaque regression. 

Facebook Comments

Recommended
Details
Comments
  • Overview

    Dr. Lorenz Raber recaps the PACMAN-AMI study and how the PCSK9 inhibitor alirocumab can aid in coronary plaque regression. 

Facebook Comments

Schedule8 Aug 2022
Webpack App